Near a 2-Year Low, Is Codexis Stock a Buy?

Investors were having their doubts about Codexis (NASDAQ: CDXS) well before the coronavirus pandemic punished stock markets. At first, those concerns focused on whether the stock could live up to its premium valuation. Later, investors grew frustrated with a slower-than-expected pace of progress in key areas for the business.

While there are certainly risks that cannot be overlooked, the small-cap stock is now trading at half the all-time high established in late 2018. Investors with a long-term mindset might be wondering if that's a price that's too good to pass up.

Image source: Getty Images.

Source Fool.com